Analysis of acyclic nucleoside modifications in siRNAs finds sensitivity at position 1 that is restored by 5′-terminal phosphorylation both in vitro and in vivo-Reference-Cited by-同舟云学术

Analysis of acyclic nucleoside modifications in siRNAs finds sensitivity at position 1 that is restored by 5′-terminal phosphorylation both in vitro and in vivo

Published:2009-11-16 Issue:2 Volume:38 Page:660-671
ISSN:1362-4962
Container-title:Nucleic Acids Research
language:en
Short-container-title:

Author:

Kenski Denise M.,Cooper Abby J.,Li Jenny J.,Willingham Aarron T.,Haringsma Henry J.,Young Tracy A.,Kuklin Nelly A.,Jones Jeffrey J.,Cancilla Mark T.,McMasters Daniel R.,Mathur Melina,Sachs Alan B.,Flanagan W. Michael

Publisher

Oxford University Press (OUP)

Subject

Genetics

Link

http://academic.oup.com/nar/article-pdf/38/2/660/16767363/gkp913.pdf

Reference39 articles.

1. siRNAs: applications in functional genomics and potential as therapeutics;Dorsett;Nat. Rev. Drug Discov.,2004

2. RNA interference is mediated by 21- and 22-nucleotide RNAs;Elbashir;Genes Dev.,2001

3. Identification of essential genes in cultured mammalian cells using small interfering RNAs;Harborth;J. Cell Sci.,2001

4. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells;Elbashir;Nature,2001

5. RNA learns from antisense;Corey;Nat. Chem. Biol.,2007

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in structural-guided modifications of siRNA;Bioorganic & Medicinal Chemistry;2024-08

2. Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges;Cell Chemical Biology;2024-01

3. Shorter Is Better: The α-(l)-Threofuranosyl Nucleic Acid Modification Improves Stability, Potency, Safety, and Ago2 Binding and Mitigates Off-Target Effects of Small Interfering RNAs;Journal of the American Chemical Society;2023-08-28

4. Acyclic (S)-glycol nucleic acid (S-GNA) modification of siRNAs improves the safety of RNAi therapeutics while maintaining potency;RNA;2023-02-01

5. Elimination of Off-Target Effect by Chemical Modification of 5′-End of siRNA;Nucleic Acid Therapeutics;2022-10-01